All news

InMed sets CVR record date ahead of Mentari merger

Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash

InMed Pharmaceuticals has set November 5, 2026, as the record date for distributing contingent value rights to shareholders ahead of its proposed merger with Mentari Therapeutics. Holders of record will receive one CVR per common share, contingent on approval of a Return of Capital Proposal at the annual meeting on November 4, 2026.

Read original source

INM company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.